Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years. A higher dose of hydroxychloroquine was associated with a greater risk of incident ...

Please provide your email address to receive an email when new articles are posted on . The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was ...

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

Although lower HCQ doses became part of guidelines to counter the risk for long-term HCQ-induced retinopathy and vision loss, optimal dosing should be reassessed given these new findings, say the ...

A cohort study of more than 3,000 persons who received hydroxychloroquine for 5 or more years with guideline-recommended serial retinopathy screening found that the overall risk for incident ...

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual scientific meeting, found that the recommended weight-based or non-weight-based dose of ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In patients with systemic lupus erythematosus, lower doses of hydroxychloroquine increase the ...

Credit: Getty Images. Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than ...

This multicenter study investigates the association between hydroxychloroquine (HCQ) dosage and COVID-19 mortality among hospitalized patients in China, aiming to clarify conflicting evidence from ...